Business briefing
LATEST ALERTS
-
Australia Research looks at opportunities for growth in cannabis sector… - Italy Vague decree on medical cannabis enters into force…
- Argentina Framework for hemp and medical cannabis in effect…
- Costa Rica Full regulation still awaited as licence requirement ends…
- California - United States Vets may be allowed to recommend cannabis for pets…
- California - United States Labelling and packaging bill moves forward…
- Connecticut - United States State’s cannabis rules amended…
- Rhode Island - United States Recreational cannabis possession and sale legalised…
- United States - Vermont CBD and delta-8 control placed in cannabis board hands…
- Canada Cannabis products recalled over inaccurate labels…
- Rhode Island - United States Bills to legalise recreational cannabis passed…
- New York - United States Arrests made over delta-8 sales…
Canadian cannabis firms look to the US market as they prepare to expand
Written by Lorraine Mullaney || 6th August 2021 || Business briefing |
A Canadian cannabis retailer is banking on boosts from cross-selling and increased social media presence to buoy US sales as it gobbles up accessory providers ...
Study raises early hopes for the use of CBD in treating nicotine withdrawal
Written by CBD-Intel || 5th August 2021 || Business briefing |
Researchers at the University of San Diego in California have published a paper showing early evidence that CBD may help ease the symptoms of nicotine withdrawal ...
Public health insurance is driving growth of the German medical cannabis market
Written by Lorraine Mullaney || 3rd August 2021 || Business briefing |
Public health insurance reimbursements and no defined list of indications for medical cannabis have helped the German medical cannabis market start to realise its massive potential ...
London firm signs deals to grow cannabis in North Macedonia for medical use
Written by Freddie Dawson || 30th July 2021 || Business briefing |
London-based AltoVerde has chosen North Macedonia as its site for growing medical cannabis to be sold throughout European markets ...
Watchdog study finds high levels of inaccuracy in delta-8 THC labels
Written by Lorraine Mullaney || 28th July 2021 || Business briefing |
Research from a CBD watchdog firm has found considerable inconsistencies between the levels of delta-8 THC stated on product labels and what was revealed by laboratory tests ...
Researchers find even synthetic CBD can degrade and produce THC if badly stored
Written by Lorraine Mullaney || 26th July 2021 || Business briefing |
Both synthetic and plant-derived CBD degrade when stored incorrectly, producing THC, according to a new study ...
Lobbyists for ‘special interests’ accused of un-American activities on cannabis
Written by CBD-Intel || 23rd July 2021 || Business briefing |
Licensing issues look set to become the next big US lobbying battleground for cannabis as money moves on from the traditional legalisation-versus-prohibition field ...
Company behind the UK’s first medical cannabis vape aims to lead a revolution
Written by CBD-Intel || 22nd July 2021 || Business briefing |
London-listed Kanabo has launched the first medical cannabis vaping product in the UK in a move the company’s founder hopes will ultimately revolutionise the way medicines are administered ...
Malawi set for its first hemp harvest following legalisation and licensing
Written by CBD-Intel || 20th July 2021 || Business briefing |
Malawi is set to have its first hemp harvest this year following the licensing of 36 companies. However, despite hopes the plant could change the country’s economic fortunes, it will continue to be strictly regulated ...
Takeover will enable more research and development towards psychedelic meds
Written by Lorraine Mullaney || 19th July 2021 || Business briefing |
The Canadian pyschedelics company MagicMed will be taken over by the US firm Enveric Biosciences in a move that will create greater research and development as well as commercialisation opportunities ...
Clinical trials to explore potential of psychedelics are on the rise in Europe
Written by Lorraine Mullaney || 16th July 2021 || Business briefing |
A range of European firms are looking to further advance research into psychedelic compounds after securing funding and backing ...
EU novel food assessment: No easy end in sight
Written by CBD-Intel || 16th July 2021 || Blog , Business briefing |
CBD growth in the UK could be boosted by a report from a new taskforce on post-Brexit regulatory change. But how likely is it that the recommendations will be implemented? ...
A long process – Europe’s still asking questions about novel food submission
Written by CBD-Intel || 14th July 2021 || Business briefing |
A year and eight months after Cibdol submitted its novel food application for EU authorisation of synthetically produced CBD, the Swiss company is still fielding questions from the European Food Safety Authority (ESFA) ...
Italian company gains EU validation for synthetic CBD novel food application
Written by Freddie Dawson || 8th July 2021 || Business briefing |
The European Commission (EC) has validated a novel food application submitted by the Italian company Farmabios for a synthetic CBD. This is the first step to gaining novel food authorisation from the European Food Safety Authority (EFSA). The...
More minor cannabinoids – could THCP and CBDP offer an interesting side dish?
Written by CBD-Intel || 1st July 2021 || Business briefing |
What are the potential implications for the cannabinoids market of two recently discovered compounds with chemical structures similar to those of CBD and THC – and what are they and their potential effects anyway? ...
Freeing the ‘green pig’ – moves afoot to press France to legalise cannabis
Written by CBD-Intel || 29th June 2021 || Business briefing |
France is lagging behind its neighbours on medical cannabis – the potential “green pig” of French agriculture – according to an author of a report which called for it to be legalised on health and finance grounds ...
And now for our next Trip, let’s head for the US with $5m spending money
Written by CBD-Intel || 29th June 2021 || Business briefing |
CBD-infused drinks company Trip is making its way into the US after it raised $5m (£3.6m) in a Series A funding round last month ...
It’s all about the brand as firms look to expand across the US and beyond
Written by Lorraine Mullaney || 22nd June 2021 || Business briefing |
Brand creation and consolidation is driving a number of major business deals in the US market ...
European ingredient popularity drives cannabinoid sector’s latest M&A action
Written by Lorraine Mullaney || 18th June 2021 || Business briefing |
Appetite for European ingredients producers appears to be driving the latest round of merger and acquisition (M&A) action in the cannabinoid sector ...
Nordic Oil seeks €5m and ‘emotional investment’ through crowd-funding
Written by CBD-Intel || 16th June 2021 || Business briefing |
Nordic Oil could become the largest European CBD brand to raise money through crowd-funding as it seeks to raise €3m-€5m through the Seedrs platform ...
Combining other topical ingredients with cannabinoids goes more than skin-deep
Written by CBD-Intel || 16th June 2021 || Business briefing |
Trends such as sustainability and organic plant-based ingredients are helping to drive the market for hemp and cannabinoid topical products even higher, with combination products all the rage ...
CBD startups exceeding all fundraising expectations as investors leap aboard
Written by Lorraine Mullaney || 15th June 2021 || Business briefing |
CBD and cannabis startups from Scotland to Florida are attracting increasing numbers of investors as they scale up their businesses and break crowd-funding records in the process ...
UK psychedelics fund puts £5m into seven companies to tackle mental health
Written by CBD-Intel || 14th June 2021 || Business briefing |
UK venture capital fund Neo Kuma has invested £5m across seven healthcare companies focused on the use of psychedelics to help combat mental health issues ...
Wave of e-commerce and retail store purchases keep High Tide on the rise
Written by Lorraine Mullaney || 1st June 2021 || Business briefing |
Canadian cannabis retailer High Tide is continuing its advance into the US market with the $26m acquisition of 80% of CBD e-commerce platform Fab Nutrition (FAB CBD) ...
Regulator’s labelling guidance could spell doom for UK sales of CBD-infused alcohol
Written by CBD-Intel || 1st June 2021 || Business briefing |
The UK alcohol industry's voluntary regulator denies being outright opposed to CBD alcoholic drinks – but moves made by one major brand suggests many see the writing on the wall for the niche sector ...
Canopy spreads, while Sundial purchases Canada’s largest cannabis retailer
Written by Lorraine Mullaney || 31st May 2021 || Business briefing |
Merger and acquisition activity remains high in the industry and two major Canadian firms – Sundial Growers and Canopy Growth – have made acquisitions this month ...
Initial results from Project Twenty21 reveal promise – and a few caveats
Written by CBD-Intel || 26th May 2021 || Business briefing |
CBD-Intel assesses how Project Twenty21 is faring as it seeks to construct a registry of medical cannabis users in the UK and Europe, providing real world data on potential efficacy ...
Small steps towards regulation raise big hopes for cannabinoids in Argentina
Written by CBD-Intel || 24th May 2021 || Business briefing |
Early moves towards a regulatory framework that would allow a cannabinoid industry in Argentina have been welcomed by insiders who hope ultimately to match or surpass the progress made by other South American nations ...
Tilray closes deal with Aphria and turns to lobbying for cannabis reform
Written by Lorraine Mullaney || 21st May 2021 || Business briefing |
The boss of the world’s new largest global cannabis company has likened the industry’s potential to that of the alcohol business before the ending of Prohibition in the early 1930s ...
Trulieve Harvest merger billed as largest in US cannabis
Written by Lorraine Mullaney || 13th May 2021 || Business briefing |
US cannabis firm Trulieve has bought Harvest Health and Recreation in a $2.1bn deal that aims to create the US’s most profitable cannabis company in what is being billed as the largest US cannabis transaction to date ...
Cannabinoids, cannabis and pain: a promising area for further research
Written by CBD-Intel || 13th May 2021 || Business briefing |
Pain is a familiar part of everybody’s life, yet it remains a remarkably hard subject to study. It therefore is unsurprising that studies have come to differing conclusions on the use of cannabis and cannabinoids for pain relief...
Covid helps fuel cannabis acquisitions by Greenlane and Dutchie
Written by Lorraine Mullaney || 11th May 2021 || Business briefing |
Two US firms, Greenlane and KushCo, have merged in a deal that aims to create a major manufacturer and distributor of cannabis accessories in the US ...
Growing medical market prompts expansion in New York and Pennsylvania
Written by Lorraine Mullaney || 7th May 2021 || Business briefing |
When Biden won the US election in November 2020 the stock market value of cannabis firms soared in expectation of a more lenient political climate under the Biden administration ...
Heading south: Valens and Canopy increase presence in US CBD market
Written by Lorraine Mullaney || 6th May 2021 || Business briefing |
Various business deals across the US and Canada see cannabis and CBD companies expanding their portfolios and growing their brands in a series of acquisitions, investments and partnerships ...
Minor cannabinoids: what are they, and how could they be of benefit?
Written by CBD-Intel || 28th April 2021 || Business briefing , Resources |
CBD-Intel offers a review of the science behind some of cannabis’s lesser-known compounds – the so-called “minor cannabinoids” – with an emphasis on their potential applications ...
CBD and Covid-19 – lab experiments show promise, but don’t hold your breath
Written by CBD-Intel || 21st April 2021 || Business briefing |
Early research into the possibility of CBD having a role to play in the fight against coronavirus infections has shown some initial promise. Any practical application remains a long way off, however ...
Cann Group teams up with Emyria to develop pharmacy grade CBD capsules
Written by Lorraine Mullaney || 21st April 2021 || Business briefing |
Australian medicinal cannabis firm Cann has moved quickly to maximise the benefits of its CBD Gelpell capsule technology by entering into a collaboration deal with healthcare technology firm Emyria ...
Jersey well placed to become Europe’s major growing hub for medical cannabis
Written by Lorraine Mullaney || 20th April 2021 || Business briefing |
Jersey could become “a cannabis hub for Europe” after Northern Leaf successfully completed a second round of funding that will enable it to complete its pharmaceutical cannabis cultivation facility on the island ...
The next big thing – or are investors in psychedelics playing the long game?
Written by CBD-Intel || 19th April 2021 || Business briefing |
While legal cannabis is still a relatively new industry, investors are already looking for the next sector to boom – and many think that will be psychedelics ...
Credit union runs into trouble with US agency over too-lax cannabis activities
Written by CBD-Intel || 16th April 2021 || Business briefing |
Access to banking services has been a problem for the legal cannabis sector in the US from the beginning – and the experience of one cooperative in Michigan shows that the relationship can be problematic for financial institutions...
Tilray expands its influence Down Under, moving on New Zealand medical market
Written by Lorraine Mullaney || 15th April 2021 || Business briefing |
Canadian cannabis firm Tilray is moving in on New Zealand’s market for medical cannabis and has received the necessary approvals to launch Tilray medical cannabis products across the country ...
‘A nice buzz in the air’ – CBD shops reopen as UK lockdown lifts
Written by CBD-Intel || 14th April 2021 || Business briefing |
As the national lockdown in the UK lifted on Monday, shoppers were excited to purchase CBD in person ...
How cannabis derivatives could help to preserve the miracle of modern medicine
Written by CBD-Intel || 13th April 2021 || Business briefing |
Could cannabinoids, including CBD, provide a partial solution to the growing danger of diseases becoming resistant to existing antibiotics? ...
Could cannabinoids help in the fight against drug-resistant bacteria?
Written by CBD-Intel || 12th April 2021 || Business briefing |
Scientific findings on the antimicrobial properties of cannabis – and in particular cannabinoids – have raised the question of whether they might play a role in combatting antibiotic-resistant bacteria such as MRSA ...
Italy issues its first licences to grow hemp and extract CBD for medical use
Written by CBD-Intel || 8th April 2021 || Business briefing |
Italy’s Ministry of Health and the Italian Medicine Agency (AIFA) have begun authorising Italian companies to manufacture hemp-derived CBD extracts for pharmaceutical purposes ...
Delta-8 THC – hot new kid on the block, or hemp’s disturbing problem child?
Written by CBD-Intel || 7th April 2021 || Business briefing |
The newest cannabinoid craze is stirring up controversy in the emerging legal hemp industry. Delta-8 THC, produced from hemp-extracted CBD, promises a legal high – but, many wonder, at what cost? ...
CBD firms find more pros than cons in legal recreational cannabis markets
Written by CBD-Intel || 6th April 2021 || Business briefing |
CBD companies see more synergies than threats from the provision of legal cannabis products in states such as Colorado, which has one of the oldest recreational cannabis markets in the US ...
US and Australian cannabis companies see great profit potential in Europe
Written by Lorraine Mullaney || 2nd April 2021 || Business briefing |
There are profits to be made from selling cannabis in Europe, according to US company Curaleaf after it signed an agreement to acquire Europe’s largest vertically integrated independent cannabis company ...